| 1 IgG (1 to 7 days) |
189 |
6679 |
| 2 IgG (8 to 14 days) |
202 |
9078 |
| 3 IgG (15 to 21 days) |
190 |
5027 |
| 4 IgG (22 to 28 days) |
42 |
940 |
| 5 IgG (29 to 35 days) |
21 |
531 |
| 6 IgM (1 to 7 days) |
126 |
4492 |
| 7 IgM (8 to 14 days) |
122 |
5577 |
| 8 IgM (15 to 21 days) |
118 |
3231 |
| 9 IgM (22 to 28 days) |
23 |
411 |
| 10 IgM (29 to 35 days) |
9 |
220 |
| 11 IgA (1 to 7 days) |
24 |
1079 |
| 12 IgA (8 to 14 days) |
22 |
1181 |
| 13 IgA (15 to 21 days) |
19 |
501 |
| 14 IgA (22 to 28 days) |
5 |
63 |
| 15 IgA (29 to 35 days) |
1 |
4 |
| 16 Total antibodies (Ab) (1 to 7 days) |
27 |
1010 |
| 17 Total antibodies (Ab) (8 to 14 days) |
29 |
1030 |
| 18 Total antibodies (Ab) (15 to 21 days) |
33 |
1016 |
| 19 Total antibodies (Ab) (22 to 28 days) |
7 |
233 |
| 20 Total antibodies (Ab) (29 to 35 days) |
6 |
147 |
| 21 IgA/IgG (1 to 7 days) |
6 |
167 |
| 22 IgA/IgG (8 to 14 days) |
5 |
170 |
| 23 IgA/IgG (15 to 21 days) |
5 |
125 |
| 24 IgA/IgG (22 to 28 days) |
2 |
74 |
| 25 IgA/IgG (29 to 35 days) |
1 |
4 |
| 26 IgA/IgM (1 to 7 days) |
1 |
52 |
| 27 IgA/IgM (8 to 15 days) |
1 |
36 |
| 28 IgG/IgM (1 to 7 days) |
103 |
3881 |
| 29 IgG/IgM (8 to 14 days) |
96 |
3948 |
| 30 IgG/IgM (15 to 21 days) |
103 |
2929 |
| 31 IgG/IgM (22 to 28 days) |
28 |
734 |
| 32 IgG/IgM (29 to 35 days) |
14 |
225 |
| 33 IgG asymptomatic (1 to 14 days post‐RT‐PCR‐positive) |
9 |
208 |
| 34 IgG asymptomatic (> 14 days post‐RT‐PCR) |
9 |
105 |
| 35 IgG asymptomatic (no timing) |
9 |
155 |
| 36 IgM asymptomatic (1 to 14 days post‐RT‐PCR‐positive) |
6 |
144 |
| 37 IgM asymptomatic (> 14 days post‐RT‐PCR) |
1 |
27 |
| 38 IgM asymptomatic (no timing) |
2 |
28 |
| 39 IgG/IgM asymptomatic (1 to 14 days post‐RT‐PCR‐positive) |
2 |
68 |
| 40 IgG/IgM asymptomatic (no timing) |
2 |
81 |
| 41 Total antibodies (Ab) asymptomatic (1 to 14 days post‐RT‐PCR‐positive) |
4 |
52 |
| 42 Total antibodies (Ab) asymptomatic (> 14 days post‐RT‐PCR) |
3 |
42 |
| 43 Total antibodies (Ab) asymptomatic (no timing) |
2 |
20 |
| 44 IgA asymptomatic (1 to 14 days post‐RT‐PCR‐positive) |
3 |
64 |
| 45 IgA asymptomatic (> 14 days post‐RT‐PCR) |
1 |
27 |
| 46 IgG convalescent |
253 |
16846 |
| 47 IgM convalescent |
125 |
7124 |
| 48 IgA convalescent |
22 |
1257 |
| 49 IgA/IgG convalescent |
4 |
157 |
| 50 IgG/IgM convalescent |
108 |
3571 |
| 51 IgA/IgM convalescent |
1 |
44 |
| 52 Total antibodies (Ab) convalescent |
58 |
7063 |
| 53 IgG Specificity Pre‐pandemic |
179 |
38090 |
| 54 IgM Specificity Pre‐pandemic |
83 |
15126 |
| 55 IgA Specificity Pre‐pandemic |
17 |
1711 |
| 56 IgG/IgM Specificity Pre‐pandemic |
68 |
9262 |
| 57 IgA/IgM Specificity Pre‐pandemic |
1 |
56 |
| 58 IgA/IgG Specificity Pre‐pandemic |
2 |
106 |
| 59 Total antibodies (Ab) Specificity Pre‐pandemic |
45 |
12207 |
| 60 IgG Specificity COVID suspects |
19 |
1569 |
| 61 IgM Specificity COVID suspects |
9 |
597 |
| 62 IgA Specificity COVID suspects |
4 |
385 |
| 63 IgG/IgM Specificity COVID suspects |
18 |
1887 |
| 64 Total antibodies (Ab) Specificity COVID suspects |
4 |
540 |
| 65 IgG Specificity current RT‐PCR‐negative |
29 |
7336 |
| 66 IgM Specificity current RT‐PCR‐negative |
20 |
2735 |
| 67 IgG/IgM Specificity current RT‐PCR‐negative |
7 |
359 |
| 68 Total antibodies (Ab) Specificity current RT‐PCR‐negative |
4 |
364 |
| 69 IgG Specificity current untested |
16 |
2561 |
| 70 IgM Specificity current untested |
10 |
2195 |
| 71 IgA Specificity current untested |
2 |
204 |
| 72 IgG/IgM Specificity current untested |
6 |
713 |
| 73 Total antibodies (Ab) Specificity current untested |
3 |
1329 |
| 74 IgG Specificity other/mixed/unclear |
28 |
7384 |
| 75 IgM Specificity other/mixed/unclear |
19 |
7153 |
| 76 IgA Specificity other/mixed/unclear |
6 |
5649 |
| 77 IgA/IgG Specificity other/mixed/unclear |
3 |
256 |
| 78 IgG/IgM Specificity other/mixed/unclear |
20 |
1887 |
| 79 Total antibodies (Ab) Specificity other/mixed/unclear |
3 |
5388 |
| 80 IgG Specificity ‐ cross‐reactivity/confounder panel |
96 |
6176 |
| 81 IgM Specificity ‐ cross‐reactivity/confounder panel |
44 |
2625 |
| 82 IgA Specificity ‐ cross‐reactivity/confounder panel |
5 |
311 |
| 83 IgG or IgM Specificity ‐ cross‐reactivity/confounder panel |
36 |
2175 |
| 84 IgA or IgG Specificity ‐ cross‐reactivity/confounder panel |
2 |
219 |
| 85 Total Ab Specificity ‐ cross‐reactivity/confounder panel |
22 |
1411 |
| 86 IgG (36 to 42 days) |
10 |
194 |
| 87 IgG (43 to 49 days) |
5 |
46 |
| 88 IgG (50‐56 days) |
5 |
51 |
| 89 IgM (36 to 42 days) |
6 |
118 |
| 90 IgM (43 to 49 days) |
4 |
34 |
| 91 IgM (50 to 56 days) |
4 |
37 |
| 92 IgA (36 to 42 days) |
1 |
2 |
| 93 IgA/IgG (36 to 42 days) |
1 |
2 |
| 94 IgG/IgM (36 to 42 days) |
4 |
62 |
| 95 IgG/IgM (43 to 49 days) |
4 |
35 |
| 96 IgG/IgM (50 to 56 days) |
4 |
38 |
